These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18037346)

  • 1. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spuriously elevated inorganic phosphate level in a multiple myeloma patient.
    Barutçuoglu B; Parildar Z; Mutaf I; Habif S; Bayindir O
    Clin Lab Haematol; 2003 Aug; 25(4):271-4. PubMed ID: 12890170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 90-year-old man with hyperphosphatemia.
    Lovekar S; Chen JL
    Am J Kidney Dis; 2011 Feb; 57(2):342-6. PubMed ID: 20951488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohyperphosphatemia and dysproteinemia.
    Busse JC; Gelbard MA; Byrnes JJ; Hellman R; Vaamonde CA
    Arch Intern Med; 1987 Nov; 147(11):2045-6. PubMed ID: 3675108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohyperphosphatemia in a hyperphosphatemic hemodialysis patient.
    Suchin EJ; Cizman B; Connolly BR; DiBattista WJ; Agus ZS
    Am J Kidney Dis; 2002 Nov; 40(5):E18. PubMed ID: 12407666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphate disorders: hyperphosphatemia or pseudohyperphosphatemia?].
    Aeberhard N; Schild C; Rodondi N; Roten-Joss C; Tänzler K
    Praxis (Bern 1994); 2014 Oct; 103(20):1203-6. PubMed ID: 25270750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin.
    Mandry JM; Posner MR; Tucci JR; Eil C
    Cancer; 1991 Sep; 68(5):1092-4. PubMed ID: 1913479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
    Cserti C; Haspel R; Stowell C; Dzik W
    Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphosphatemia in multiple myeloma.
    Oren S; Feldman A; Turkot S; Lugassy G
    Ann Hematol; 1994 Jul; 69(1):41-3. PubMed ID: 8061106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate levels.
    Adler SG; Laidlaw SA; Lubran MM; Kopple JD
    Am J Kidney Dis; 1988 Mar; 11(3):260-3. PubMed ID: 3125742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbances of platelet function in patients with multiple myeloma.
    Czestochowska E; Tymiński W; Górski J; Umiastowski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):845-51. PubMed ID: 2453414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy of multiple myeloma: cytostatics and plasmapheresis].
    Górski J; Kicińska M
    Acta Haematol Pol; 1990; 21(2):166-72. PubMed ID: 2131716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.